+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Relenza"

H3N2 infection - Pipeline Insight, 2024 - Product Thumbnail Image

H3N2 infection - Pipeline Insight, 2024

  • Drug Pipelines
  • February 2024
  • 80 Pages
  • Global
From
From
Global Antiviral Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

Global Antiviral Drugs Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Relenza is an antiviral drug used to treat influenza, commonly known as the flu. It is a neuraminidase inhibitor, meaning it works by blocking the activity of the neuraminidase enzyme, which is essential for the virus to spread within the body. Relenza is used to treat both seasonal and pandemic influenza, and is approved for use in adults and children over the age of five. It is usually taken as an inhaled powder, but can also be taken as an oral tablet. Relenza is one of several drugs used to treat infectious diseases, which are caused by microorganisms such as bacteria, viruses, fungi, and parasites. Other drugs used to treat infectious diseases include antibiotics, antifungals, antivirals, and antiparasitics. The Relenza market is highly competitive, with several companies offering the drug. These include GlaxoSmithKline, Novartis, Sanofi, and Mylan. Show Less Read more